Results 181 to 190 of about 3,107 (205)

Onasemnogene-abeparvovec/prednisolone

Reactions Weekly, 2022
openaire   +2 more sources

Intrathecal onasemnogene abeparvovec in treatment-naive patients with spinal muscular atrophy: a phase 3, randomized controlled trial.

Nature Medicine
Crystal M Proud, D. Vũ, J. Wilmshurst, O. Sanmaneechai, S. Gulati, H. Xiong, H. C. Moreno, S. Tay, M. Thong, A. Born, Adriana Banzzatto Ortega, Y. Jong, M. Al-muhaizea, Anna W Lee, J. Visootsak, S. Tauscher‐Wisniewski, Iulian Alecu, R. Parlikar, Richard S. Finkel   +18 more
semanticscholar   +1 more source

Nusinersen/onasemnogene abeparvovec

Reactions Weekly, 2022
openaire   +1 more source

Anakinra/onasemnogene abeparvovec

Reactions Weekly, 2023
openaire   +1 more source

Siponimod, onasemnogene abeparvovec-xioi, and brexanolone

Journal of the American Pharmacists Association, 2020
Daniel A, Hussar, Alexandra E, Cerino
openaire   +2 more sources

Nusinersen/onasemnogene-abeparvovec

Reactions Weekly, 2020
openaire   +2 more sources

Onasemnogene-abeparvovec/prednisone

Reactions Weekly, 2022
openaire   +1 more source

Cotrimoxazole/onasemnogene-abeparvovec

Reactions Weekly, 2022
openaire   +1 more source

Nusinersen/onasemnogene-abeparvovec/risdiplam

Reactions Weekly, 2022
openaire   +1 more source

Pilocytic Astrocytoma in a Child with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec.

Molecular Therapy
D. Holzwarth, G. Calaminus, Johannes Friese, T. Sejersen, Hildegard Büning, Philipp John-Neek, Antonella L. Bastone, Michael Rothe, Keith Mansfield, S. Libertini, Valerie Dubost, Brent J Kuzmiski, I. Alecu, Ivan Labik, Jan Kirschner   +14 more
semanticscholar   +1 more source